Have you or a loved one suffered health complications after undergoing breast implant surgery with an Allergan textured breast implant? If so, we’re here to help.Learn More
In July 2019, the U.S. Food and Drug Administration (FDA) requested that Allergan recall its BIOCELL textured breast implants and tissue expanders after new data found an increased risk of a rare cancer called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) associated with the implants.
The FDA first identified a possible association between breast implants and ALCL in 2011. At the time of the recall there were 573 unique cases of BIA-ALCL and 33 deaths globally – of the 573 unique cases, 481 were attributed to Allergan implants. According to the FDA’s analysis, the risk of BIA-ALCL is approximately six times higher with Allergan BIOCELL textured implants than with textured implants from other manufacturers.
Our attorneys at Constant Legal Group are backed by 18+ years of experience and education. Not only are we qualified to take on your case, but we care deeply about making sure you feel in the know and confident about your situation.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is not actually breast cancer – it’s a type of non-Hodgkin lymphoma that can develop around breast implants. Although BIA-ALCL is mostly found in the scar tissue and fluid near the implant, it can also spread throughout the body as well. BIA-ALCL often develops eight to ten years after surgery. Common symptoms include:
If you or someone you love have suffered from health complications, including BIA-ALCL, after undergoing breast implant surgery with one of the textured breast implants involved in the recall, you may be entitled to financial compensation by filing a lawsuit against Allergan.
Fill out our intake form on this page for a 100% free and no-obligation review of your case. Constant Legal Group is here to help – we’d be honored to speak with you.